Exploitation, brutality and misery: How the opium trade shaped the modern world
The opium trade that impoverished and crippled India also financed and helped forge the modern state
The pill that’s roiling US drug regulation
The hard right is challenging FDA’s authority to regulate drugs with its lawsuit to ban America’s most used abortion pill
Suspect claims in Teva’s suit against Cipla
The US Federal Trade Commission has warned the Israeli drug firm its patents are wrongful as it sues Cipla aggressively
US food labels will now display calories per serving and for entire product
Change in accordance with new FDA rules, intended to make consumers aware
FDA orders withdrawal of ranitidine drug from markets
US drug regulator completes seven-month investigation, finds high levels of carcinogen
Popular drug ranitidine recalled after carcinogenic qualities confirmed
The drug has been found to have levels of a carcinogen above what the US FDA prescribes
FDA gives EUA to first-ever breath test to detect a COVID-19 infection
A positive test, however, should be confirmed with a Polymerase Chain Reaction test
Experts suggest updating vaccines for new variants. How does it work & what are the challenges?
It is easier to update certain vaccine platforms than others, say experts
COVID-19: US FDA grants emergency authorisation for remdesivir
EUA doesn't equal final nod; China trial painted different picture
What is ‘dry ice’, at the centre of the Gurugram restaurant incident?
The solid form of carbon dioxide commonly used as a cooling agent in ice cream & frozen desserts must never be touched with ‘…
How safe is your hand sanitiser
The government hasn’t had much control over India’s hand sanitising manufacturers, who have mushroomed amid the COVID-19 pandemic
Anti-mifepristone court decisions rely on medical misinformation about abortion & questionable legal reasoning
The Food and Drug Administration approved mifepristone in the year 2000 for use in medication abortion up to seven weeks
What the Dengvaxia episode teaches us
Introducing a vaccine prematurely and in haste, and exposing whole populations to considerable risks must never be repeated again
Over half the antibiotic formulations India used in 2019 were unapproved
Despite being the largest antibiotic consumer in absolute volume globally, India lacks a formal system of antibiotic use surveillance
FDA approves marketing of 8 smokeless tobacco products in US
Using General Snus instead of tobacco cigarettes can cut risk of mouth cancer, heart disease, lung cancer, stroke, emphysema, and chronic …
Johnson & Johnson recalls 33,000 talcum powder bottles after asbestos traces found
The multinational corporation says it will conduct an investigation parallel to the one being conducted by US FDA
Number of antibiotics, investment not sufficient to minimise threat of wide-spread infection
Of the 12 antibiotics companies that have gone public in the past 10 years, only 5 are still active today
Study claims asthma drug can help fight COVID-19
Montelukast has been around for more than 20 years and is usually prescribed to reduce inflammation caused by conditions like asthma, hay …
Update COVID-19 vaccine to target omicron variants: Advisory panel to USFDA
Unclear which combination of updated vaccine will work best; body expected to decide by July
Ivermectin: why a potential COVID treatment isn’t recommended for use
There is currently insufficient evidence to support the use of ivermectin in treatment of COVID-19
Indian pharma firms receive 34% of FDA warnings this year
These warnings were for misbranding, selling unapproved medicines and violating Current Good Management Practices
Coronavirus update: US FDA cautions consumers against toxin in hand sanitisers
India registers highest single-day spike of 66,999 cases August 13; 942 deaths added in 24 hours
Donald Trump is taking hydroxychloroquine to ward off COVID-19. Is that wise?
There is a 20% genetic difference between SARS-CoV-2 and previous SARS coronavirus, meaning we should not assume a drug shown to act against SARS …
The world needs pharmaceuticals from China and India to beat COVID-19
Chinese manufacturers make around 40% of all APIs used worldwide; China, India are the source of 75-80% of APIs imported to US
COVID-19: Centre doesn’t clarify basis for CDSCO authorising remdesivir
Government also does not provide clarity about whether remdesivir should be given to only severe patients